Merck & Co Inc (MRK)

MRK (NYSE:Drugs) EQUITY
$63.64
pos +0.30
+0.47%
Today's Range: 63.46 - 64.11 | MRK Avg Daily Volume: 10,859,100
Last Update: 03/29/17 - 4:01 PM EDT
Volume: 8,135,333
YTD Performance: 7.59%
Open: $63.67
Previous Close: $63.34
52 Week Range: $52.44 - $66.80
Oustanding Shares: 2,745,571,067
Market Cap: 173,492,635,724
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 7
Moderate Buy 1 1 1 0
Hold 3 3 3 6
Moderate Sell 1 1 1 0
Strong Sell 0 0 0 0
Mean Rec. 1.68 1.68 1.68 1.92
Latest Dividend: 0.47
Latest Dividend Yield: 2.98%
Dividend Ex-Date: 03/13/17
Price Earnings Ratio: 44.82
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
44.82 44.80 30.30
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
6.87% 19.89% 13.15%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.80 -0.10 -0.03
Net Income -11.60 -0.10 -0.04
EPS -9.60 -0.10 -0.02
Earnings for MRK:
EBITDA 11.47B
Revenue 39.81B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $0.83 $0.86 $3.82 $4.18
Number of Analysts 6 5 9 8
High Estimate $0.89 $0.92 $3.88 $4.73
Low Estimate $0.73 $0.81 $3.77 $4.00
Prior Year $0.89 $0.93 $3.78 $3.82
Growth Rate (Year over Year) -6.55% -7.96% 1.03% 9.49%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Jim Cramer

 | Mar 23, 2017 | 3:16 PM EDT
Get your plan in place, but understand that the Republic is not in jeopardy.
By

Doug Kass

 | Mar 13, 2017 | 4:00 PM EDT
"I would describe today's market action as "benign." And that applies to almost every asset class." -- Kass Diary
RMPIA
By

Doug Kass

 | Mar 13, 2017 | 12:47 PM EDT
Healthcare stocks had a heckuva four-year period of over-performance that ended in the summer of 2015. Since then the Health Care Select Sector SPDR ETF (XLV) (40% pharma and 15% biotech) has had a series of trading-range moves as sector prices lagged. Last year more than $18 billion was redeemed out of the healthcare ETFs, according to Morningstar. However there are some technical signposts that the two-year period of underperformance might be ending, as a basing seems likely. Look at the chart and note the recent higher high.
RMPIA
By

Jim Cramer

 | Mar 7, 2017 | 2:00 PM EST
Drug companies are the latest targets/beneficiaries.
RMPIA
By

Jim Cramer

 | Mar 6, 2017 | 6:50 AM EST
Bull market number one, perhaps of all time: the financials.
By

Jim Cramer

 | Feb 28, 2017 | 11:30 AM EST
Let's recognize that some moves are simply related to bonds, which are in the grips of a bizarre developed-world shortage.
RMPIA
By

Jim Cramer

 | Feb 24, 2017 | 6:08 AM EST
You have to keep up with the sector rotations.
RMPIA
By

Jim Cramer

 | Feb 22, 2017 | 1:57 PM EST
These may be uncharted waters, but they're not necessarily expensive.
RMPIA
By

Jim Cramer

 | Feb 22, 2017 | 11:45 AM EST
Icahn may have a tough time finding interest in this behemoth.
RMPIA
By

Bruce Kamich

 | Feb 16, 2017 | 11:18 AM EST
You might want to review your holdings in the sector.
I've been suspect of CSCO since early this month ...
I forgot to list my short positions in RH puts in my disclosure on retail shares.

Paul
Retails shares, almost without exception, are surging higher from very previously, very de...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.